1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
(
- Contribution to journal › Article
- 2023
-
Mark
A comparison of men and women undergoing septoplasty—the Swedish national septoplasty register
(
- Contribution to journal › Article
- 2021
-
Mark
Nasal symptoms increase the risk of snoring and snoring increases the risk of nasal symptoms. A longitudinal population study
(
- Contribution to journal › Article
- 2020
-
Mark
Rituximab in multiple sclerosis at general hospital level
(
- Contribution to journal › Article
- 2016
-
Mark
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.
(
- Contribution to journal › Article